Author Archives: admin

First-in-Human Study of Novel Oral Dual-Acting Antibody in Development for Treatment of Patients with Inflammatory Bowel Disease SALT LAKE CITY, UT, UNITED STATES, November 1, 2023 /EINPresswire.com/ — Sorriso Pharmaceuticals, a biopharmaceutical company developing novel oral antibodies in immune-mediated disease, today announced that the first subject has been dosed in the company’s Phase 1/1b clinical […]

SALT LAKE CITY – October 27, 2023 –BioUtah, Utah’s trade association serving the state’s life sciences community, announced today Myles Greenberg, MD, MBA, CEO of Alucent Biomedical, as the new board chair, effective January 2024. Dr. Greenberg, an experienced life sciences entrepreneur, venture investor, and board-certified emergency physician, succeeds Andrea Kendell, chief financial officer at […]

Partnership covers development of lab-developed and distributable kit-based companion diagnostic tests Combined strengths in assay development, clinical testing, and regulatory approvals offers pharma partners comprehensive global companion diagnostic solutions based on PCR, digital PCR (using the QIAcuity system), and NGS Future projects may include advanced analysis and accessibility of measurable residual disease (MRD) and homologous […]

SALT LAKE CITY, UT, October, 18, 2023 – Seek Labs, a healthcare innovations company doing research in infectious disease diagnostic systems and pharmaceuticals, is pleased to announce its participation at the Animal Health, Nutrition & Technology Innovation Asia Summit in Tokyo, Japan. Craig Mosman, Chief Business Development Officer, was invited to speak on behalf of […]

Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding Salt Lake City, UT – October 18, 2023 – DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced a basic science Cooperative Research and […]

Funding to Support Research and Expanded Access of Investigational Drug in ALS SALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological […]

LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children’s Hospital […]

Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in […]

SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its second annual Environmental, Social and Governance report, highlighting key efforts that reflect its commitment to conduct operations as a responsible, equitable and sustainable partner in the healthcare industry. “At Myriad, […]

By their very nature, rare diseases impact a smaller portion of the population compared to conditions like cancer or the flu. While these diseases are less common, those affected by them, along with University of Utah researchers, are actively searching for a cure. Treating patients as individuals: Clement Chow Read more about Clement Chow’s research […]

19.3 month significant survival difference for CNM-Au8® treated participants versus placebo 52% significant decreased risk of ALS clinical worsening events Over 475 years of CNM-Au8 treatment exposure without any identified safety signals SALT LAKE CITY, Aug. 29, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) through its wholly owned subsidiary Clene Nanomedicine Inc., today announced […]

Crews to topple final guard tower and showcase sustainable demolition practices   WHAT: Members of the media are invited to get a close-up look at demolition efforts currently underway at The Point. Attendees will get exclusive views of the preserved prison chapel called the “Chapel by the Wayside” and the state-of-the-art crushing facility used to […]